Table 3.
Extrapulmonary TB | 22 (62.9%) |
Lymphadenitis | 10 (28.6%) |
Osseous | 6 (17.1%) |
Urogenital | 2 (5.7%) |
CNS | 2 (5.7%) |
Mediastinal | 1 (2.9%) |
Pleural | 1 (2.9%) |
Pulmonary TB* | 13 (37.1%) |
Disseminated | 10/13 (76.9%) |
Lymphadenitis+pulmonary | 1 |
Lymphadenitis+abdominal+pulmonary | 1 |
Lymphadenitis+mediastinal+pulmonary | 1 |
Osseous+lymphadenitis+pleural-pulmonary | 1 |
CNS+pulmonary | 1 |
CNS+lymphadenitis+pulmonary | 1 |
CNS+osseous+pulmonary | 1 |
Abdominal+pleural+thymus+pulmonary | 1 |
Abdominal+pulmonary | 1 |
Scrotal+pulmonary | 1 |
Restricted to the lungs | 3/13 (23.1%) |
*Smear-positive: 4/1.3 (30.8%); smear negative - culture-positive: 9/13 (69.2%)